CSPC Pharmaceutical Group Limited

CSPCY | OTC

$4.07

+$0.13 (+3.30%)

Nov 2, 2026, 11:13 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Revenue	25.33B	29.54B	31.47B	31.59B	27.41B	23.58B
Cost of Revenue	8.72B	8.87B	9.28B	8.86B	6.62B	5.92B
Gross Profit	16.62B	20.67B	22.19B	22.73B	20.79B	17.67B
Operating Income	3.87B	5.45B	7.01B	6.93B	6.14B	5.14B
Interest Income	190.8M	n/a	n/a	n/a	n/a	n/a
Pretax Income	4.68B	5.68B	7.39B	7.74B	6.73B	6.04B
Net Income	3.78B	4.41B	5.88B	6.22B	5.51B	4.88B
Selling & General & Admin	7.29B	9.93B	10.35B	11.72B	11.27B	9.8B
Research & Development	5.66B	5.29B	4.83B	4.07B	3.38B	2.73B
Other Expenses	-198.35M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	12.75B	15.22B	15.19B	15.8B	14.64B	12.53B
Interest Expense	37.6M	43.67M	25.9M	24.89M	7.66M	12.23M
Selling & Marketing Expenses	6.46B	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	21.46B	24.09B	24.47B	24.66B	21.26B	18.44B
Income Tax Expense	907.61M	1.26B	1.32B	1.38B	1.14B	1.1B
Shares Outstanding (Basic)	11.42B	11.74B	11.87B	11.92B	11.95B	11.95B
Shares Outstanding (Diluted)	11.42B	11.74B	11.87B	11.92B	11.95B	11.96B
EPS (Basic)	0.33	0.38	0.50	0.52	0.46	0.41
EPS (Diluted)	0.33	0.38	0.49	0.52	0.46	0.41
EBITDA	5.24B	7.18B	8.59B	8.85B	7.57B	6.8B
EBIT	3.87B	5.82B	7.47B	7.78B	6.72B	6.04B
Depreciation & Amortization	1.37B	1.36B	1.11B	1.07B	849.47M	763.04M